• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酪氨酸磷酸酯酶受体 Z 在中枢神经系统疾病中的作用。

Protein Tyrosine Phosphatase Receptor Type Z in Central Nervous System Disease.

机构信息

Department of Neurosurgery, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.

Department of Clinical Laboratory Sciences, School of Health Sciences, Fukushima Medical University, Fukushima 960-8516, Japan.

出版信息

Int J Mol Sci. 2022 Apr 16;23(8):4414. doi: 10.3390/ijms23084414.

DOI:10.3390/ijms23084414
PMID:35457233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9024684/
Abstract

Gliomas are among the most common tumors of the central nervous system and include highly malignant subtypes, such as glioblastoma, which are associated with poor prognosis. Effective treatments are therefore urgently needed. Despite the recent advances in neuroimaging technologies, differentiating gliomas from other brain diseases such as multiple sclerosis remains challenging in some patients, and often requires invasive brain biopsy. Protein tyrosine phosphatase receptor type Z (PTPRZ) is a heavily glycosylated membrane protein that is highly expressed in the central nervous system. Several reports analyzing mouse tumor models suggest that PTPRZ may have potential as a therapeutic target for gliomas. A soluble cleaved form of PTPRZ (sPTPRZ) in the cerebrospinal fluid is markedly upregulated in glioma patients, making it another promising diagnostic biomarker. Intriguingly, PTPRZ is also involved in the process of remyelination in multiple sclerosis. Indeed, lowered PTPRZ glycosylation by deletion of the glycosyltransferase gene leads to reduced astrogliosis and enhanced remyelination in mouse models of demyelination. Here, we review the expression, molecular structure, and biological roles of PTPRZ. We also discuss glioma and demyelinating diseases, as well as the pathological role of PTPRZ and its application as a diagnostic marker and therapeutic target.

摘要

神经胶质瘤是中枢神经系统最常见的肿瘤之一,包括高度恶性的亚型,如胶质母细胞瘤,其预后较差。因此,迫切需要有效的治疗方法。尽管神经影像学技术最近有了进步,但在某些患者中,区分神经胶质瘤与其他脑部疾病(如多发性硬化症)仍然具有挑战性,通常需要进行有创性的脑活检。蛋白酪氨酸磷酸酯酶受体 Z 型(PTPRZ)是一种高度糖基化的膜蛋白,在中枢神经系统中高度表达。几项分析小鼠肿瘤模型的报告表明,PTPRZ 可能是神经胶质瘤的潜在治疗靶点。脑脊液中可溶性裂解形式的 PTPRZ(sPTPRZ)在神经胶质瘤患者中明显上调,使其成为另一种有前途的诊断生物标志物。有趣的是,PTPRZ 还参与多发性硬化症的髓鞘再生过程。事实上,通过删除糖基转移酶基因降低 PTPRZ 的糖基化,会导致脱髓鞘小鼠模型中的星形胶质细胞增生减少和髓鞘再生增强。在这里,我们回顾了 PTPRZ 的表达、分子结构和生物学作用。我们还讨论了神经胶质瘤和脱髓鞘疾病,以及 PTPRZ 的病理作用及其作为诊断标志物和治疗靶点的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/6b9415fc0acd/ijms-23-04414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/56a92bb6d4f6/ijms-23-04414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/89659d05e194/ijms-23-04414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/6b9415fc0acd/ijms-23-04414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/56a92bb6d4f6/ijms-23-04414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/89659d05e194/ijms-23-04414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/794e/9024684/6b9415fc0acd/ijms-23-04414-g003.jpg

相似文献

1
Protein Tyrosine Phosphatase Receptor Type Z in Central Nervous System Disease.蛋白酪氨酸磷酸酯酶受体 Z 在中枢神经系统疾病中的作用。
Int J Mol Sci. 2022 Apr 16;23(8):4414. doi: 10.3390/ijms23084414.
2
Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma.脑脊液中的可溶性蛋白酪氨酸磷酸酶Z型受体(PTPRZ)是胶质瘤的一种潜在诊断标志物。
Neurooncol Adv. 2020 Apr 30;2(1):vdaa055. doi: 10.1093/noajnl/vdaa055. eCollection 2020 Jan-Dec.
3
Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.多效生长因子介导的蛋白酪氨酸磷酸酶Z失活通过激活少突胶质前体细胞分化促进髓鞘再生
J Neurosci. 2015 Sep 2;35(35):12162-71. doi: 10.1523/JNEUROSCI.2127-15.2015.
4
Brain-specific glycosylation enzyme GnT-IX maintains levels of protein tyrosine phosphatase receptor PTPRZ, thereby mediating glioma growth.脑特异性糖基化酶 GnT-IX 维持蛋白酪氨酸磷酸酶受体 PTPRZ 的水平,从而介导神经胶质瘤的生长。
J Biol Chem. 2023 Sep;299(9):105128. doi: 10.1016/j.jbc.2023.105128. Epub 2023 Aug 4.
5
Brain-specific glycosylation of protein tyrosine phosphatase receptor type Z (PTPRZ) marks a demyelination-associated astrocyte subtype.脑特异糖基化的蛋白酪氨酸磷酸酶受体 Z 型(PTPRZ)标志着一种与脱髓鞘相关的星形胶质细胞亚型。
J Neurochem. 2023 Aug;166(3):547-559. doi: 10.1111/jnc.15820. Epub 2023 Apr 16.
6
The PTN-PTPRZ signal activates the AFAP1L2-dependent PI3K-AKT pathway for oligodendrocyte differentiation: Targeted inactivation of PTPRZ activity in mice.PTN-PTPRZ 信号激活 AFAP1L2 依赖性 PI3K-AKT 通路促进少突胶质细胞分化:靶向敲除小鼠 PTPRZ 活性。
Glia. 2019 May;67(5):967-984. doi: 10.1002/glia.23583. Epub 2019 Jan 22.
7
Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity: PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION.硫酸软骨素(CS)修饰在调节蛋白酪氨酸磷酸酶Z型受体(PTPRZ)活性中的作用:多效生长因子-PTPRZ-A信号传导参与少突胶质细胞分化。
J Biol Chem. 2016 Aug 26;291(35):18117-28. doi: 10.1074/jbc.M116.742536. Epub 2016 Jul 21.
8
Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility.蛋白酪氨酸磷酸酶PTPRZ-B的细胞内和细胞外结构域对胶质瘤细胞的生长和运动具有不同的调节作用。
Oncotarget. 2014 Sep 30;5(18):8690-702. doi: 10.18632/oncotarget.2366.
9
A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z.头部到尾部的二聚化对于配体诱导的蛋白酪氨酸受体 Z 型失活具有生理相关性。
J Biol Chem. 2019 Oct 11;294(41):14953-14965. doi: 10.1074/jbc.RA119.007878. Epub 2019 Aug 15.
10
A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions.蛋白酪氨酸磷酸酶Z型受体在脱髓鞘损伤功能恢复中的关键作用。
Nat Genet. 2002 Nov;32(3):411-4. doi: 10.1038/ng1004. Epub 2002 Sep 30.

引用本文的文献

1
Astrocyte-derived PTPRZ1 regulates astrocyte morphology and excitatory synaptogenesis.星形胶质细胞衍生的PTPRZ1调节星形胶质细胞形态和兴奋性突触形成。
bioRxiv. 2025 May 1:2025.04.30.651514. doi: 10.1101/2025.04.30.651514.
2
Single-cell transcriptomics of vascularized human brain organoids decipher lineage-specific stress adaptation in fetal hypoxia-reoxygenation injury.血管化人脑海绵体的单细胞转录组学解析胎儿缺氧-复氧损伤中的谱系特异性应激适应
Theranostics. 2025 Jun 9;15(14):7001-7024. doi: 10.7150/thno.117001. eCollection 2025.
3
Astrocytic pleiotrophin deficiency in the prefrontal cortex contributes to stress-induced depressive-like responses in male mice.

本文引用的文献

1
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
2
Myelin Repair: From Animal Models to Humans.髓鞘修复:从动物模型到人类
Front Cell Neurosci. 2021 Apr 14;15:604865. doi: 10.3389/fncel.2021.604865. eCollection 2021.
3
Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma.脑脊液中的可溶性蛋白酪氨酸磷酸酶Z型受体(PTPRZ)是胶质瘤的一种潜在诊断标志物。
前额叶皮质中星形胶质细胞源性多效蛋白缺乏导致雄性小鼠出现应激诱导的抑郁样反应。
Nat Commun. 2025 Mar 14;16(1):2528. doi: 10.1038/s41467-025-57924-1.
4
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC.蛋白酪氨酸磷酸酶受体型Z1(PTPRZ1)使RNF26去磷酸化并使其稳定,从而降低酪氨酸激酶抑制剂(TKIs)和程序性死亡蛋白1(PD -1)阻断剂在透明细胞肾细胞癌(ccRCC)中的疗效。
Oncogene. 2024 Dec;43(50):3633-3644. doi: 10.1038/s41388-024-03198-8. Epub 2024 Oct 23.
5
Analysis of Receptor-Type Protein Tyrosine Phosphatase Extracellular Regions with Insights from AlphaFold.利用 AlphaFold 分析受体型蛋白酪氨酸磷酸酶细胞外区域
Int J Mol Sci. 2024 Jan 9;25(2):820. doi: 10.3390/ijms25020820.
6
Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy.胶质瘤中的异常糖基化:生物学、生物标志物及靶向治疗方面的相关变化
Biomark Res. 2023 May 26;11(1):54. doi: 10.1186/s40364-023-00491-8.
7
Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis.蛋白酪氨酸磷酸酯酶受体 Zeta 1 作为癌症治疗和诊断的潜在靶点。
Int J Mol Sci. 2023 Apr 30;24(9):8093. doi: 10.3390/ijms24098093.
8
Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?经典蛋白酪氨酸磷酸酶基因的可遗传变异:它们会被证明是无辜的还是有罪的?
Front Cell Dev Biol. 2023 Jan 23;10:1051311. doi: 10.3389/fcell.2022.1051311. eCollection 2022.
9
The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells.糖蛋白 M6a 与脑胶质瘤干细胞的侵袭性和放射抵抗性有关。
Cells. 2022 Jul 6;11(14):2128. doi: 10.3390/cells11142128.
Neurooncol Adv. 2020 Apr 30;2(1):vdaa055. doi: 10.1093/noajnl/vdaa055. eCollection 2020 Jan-Dec.
4
A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z.头部到尾部的二聚化对于配体诱导的蛋白酪氨酸受体 Z 型失活具有生理相关性。
J Biol Chem. 2019 Oct 11;294(41):14953-14965. doi: 10.1074/jbc.RA119.007878. Epub 2019 Aug 15.
5
GlcNAc6ST3 is a keratan sulfate sulfotransferase for the protein-tyrosine phosphatase PTPRZ in the adult brain.GlcNAc6ST3 是成年大脑中蛋白酪氨酸磷酸酶 PTPRZ 的一种硫酸角质素转移酶。
Sci Rep. 2019 Mar 13;9(1):4387. doi: 10.1038/s41598-019-40901-2.
6
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.继发性胶质母细胞瘤的突变特征指导脑肿瘤中针对 MET 的靶向试验。
Cell. 2018 Nov 29;175(6):1665-1678.e18. doi: 10.1016/j.cell.2018.09.038. Epub 2018 Oct 18.
7
New Ways of "Seeing" the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis.探索多发性硬化斑块发病机制的机械异质性的新方法。
J Neuroophthalmol. 2018 Mar;38(1):91-100. doi: 10.1097/WNO.0000000000000633.
8
Multiple Sclerosis Pathology.多发性硬化症病理学。
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):a028936. doi: 10.1101/cshperspect.a028936.
9
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
10
Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.开发受体蛋白酪氨酸磷酸酶β/ζ(PTPRZ1)抑制剂作为中枢神经系统疾病的候选药物。
Eur J Med Chem. 2018 Jan 20;144:318-329. doi: 10.1016/j.ejmech.2017.11.080. Epub 2017 Nov 28.